X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Merck Ltd with GSK Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MERCK LTD vs GSK PHARMA - Comparison Results

MERCK LTD    Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

GSK PHARMA 
   Change

GSK Pharma is one of the leading MNC pharma companies in the Indian market. It is a 50.7% subsidiary of GlaxoSmithKline Plc, one of the world's largest pharma companies. GSK Pharma's product portfolio boasts of some of the leading brands like Augment... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MERCK LTD GSK PHARMA MERCK LTD/
GSK PHARMA
 
P/E (TTM) x 44.2 60.1 73.5% View Chart
P/BV x 6.4 11.2 57.3% View Chart
Dividend Yield % 0.5 2.6 20.6%  

Financials

 MERCK LTD   GSK PHARMA
EQUITY SHARE DATA
    MERCK LTD
Dec-17
GSK PHARMA
Mar-18
MERCK LTD/
GSK PHARMA
5-Yr Chart
Click to enlarge
High Rs1,3582,760 49.2%   
Low Rs9332,040 45.7%   
Sales per share (Unadj.) Rs665.0339.0 196.2%  
Earnings per share (Unadj.) Rs56.641.4 136.6%  
Cash flow per share (Unadj.) Rs72.545.9 157.9%  
Dividends per share (Unadj.) Rs15.0035.00 42.9%  
Dividend yield (eoy) %1.31.5 89.8%  
Book value per share (Unadj.) Rs441.7242.9 181.9%  
Shares outstanding (eoy) m16.6084.70 19.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.77.1 24.3%   
Avg P/E ratio x20.257.9 34.9%  
P/CF ratio (eoy) x15.852.3 30.2%  
Price / Book Value ratio x2.69.9 26.2%  
Dividend payout %26.584.5 31.4%   
Avg Mkt Cap Rs m19,011203,280 9.4%   
No. of employees `0001.5NA-   
Total wages/salary Rs m1,6965,234 32.4%   
Avg. sales/employee Rs Th7,150.0NM-  
Avg. wages/employee Rs Th1,098.7NM-  
Avg. net profit/employee Rs Th608.2NM-  
INCOME DATA
Net Sales Rs m11,04028,715 38.4%  
Other income Rs m240545 43.9%   
Total revenues Rs m11,27929,260 38.5%   
Gross profit Rs m1,3765,059 27.2%  
Depreciation Rs m264380 69.5%   
Interest Rs m02 0.0%   
Profit before tax Rs m1,3525,222 25.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m170178 95.5%   
Tax Rs m5831,892 30.8%   
Profit after tax Rs m9393,508 26.8%  
Gross profit margin %12.517.6 70.8%  
Effective tax rate %43.136.2 119.0%   
Net profit margin %8.512.2 69.6%  
BALANCE SHEET DATA
Current assets Rs m7,52321,815 34.5%   
Current liabilities Rs m2,25315,999 14.1%   
Net working cap to sales %47.720.3 235.7%  
Current ratio x3.31.4 244.9%  
Inventory Days Days5264 82.0%  
Debtors Days Days4119 217.0%  
Net fixed assets Rs m1,24012,475 9.9%   
Share capital Rs m166847 19.6%   
"Free" reserves Rs m7,16719,726 36.3%   
Net worth Rs m7,33320,573 35.6%   
Long term debt Rs m06 0.0%   
Total assets Rs m9,91239,475 25.1%  
Interest coverage xNM2,612.0-  
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.10.7 153.1%   
Return on assets %9.58.9 106.6%  
Return on equity %12.817.1 75.1%  
Return on capital %20.826.2 79.1%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m1,015564 179.9%   
Fx outflow Rs m3,0437,429 41.0%   
Net fx Rs m-2,028-6,865 29.5%   
CASH FLOW
From Operations Rs m5374,728 11.3%  
From Investments Rs m-476-1,042 45.7%  
From Financial Activity Rs m-220-3,066 7.2%  
Net Cashflow Rs m-160620 -25.7%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 51.8 50.7 102.2%  
Indian inst/Mut Fund % 18.2 10.2 178.4%  
FIIs % 1.0 23.8 4.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.1 15.4 189.0%  
Shareholders   28,591 102,036 28.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MERCK LTD With:   ORCHID PHARMA LTD  CIPLA  ASTRAZENECA PHARMA  SUVEN LIFE  STERLING BIOTECH  

Compare MERCK LTD With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Open on a Positive Note; Realty & Auto Stocks Lead(09:30 am)

Asian stock markets are higher today as Chinese and Hong Kong shares show gains. The Shanghai Composite is up 0.2% while the Hang Seng is up 1.6%.

Related Views on News

MERCK LTD Announces Quarterly Results (2QFY19); Net Profit Up 29.8% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, MERCK LTD has posted a net profit of Rs 411 m (up 29.8% YoY). Sales on the other hand came in at Rs 2 bn (down 27.7% YoY). Read on for a complete analysis of MERCK LTD's quarterly results.

GSK PHARMA Announces Quarterly Results (2QFY19); Net Profit Down 22.7% (Quarterly Result Update)

Oct 23, 2018 | Updated on Oct 23, 2018

For the quarter ended September 2018, GSK PHARMA has posted a net profit of Rs 1 bn (down 22.7% YoY). Sales on the other hand came in at Rs 8 bn (down 2.4% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

My Top 7 Stocks to Buy Now(The 5 Minute Wrapup)

Nov 30, 2018

Of all the stocks that you could buy in this market, I've picked the seven best safe stocks that offer the ideal combination of safety and profit.

4 Rebound Stocks to Profit from the Current Small Cap Crash(Profit Hunter)

Dec 3, 2018

Indian small cap space is offering a discount season. Make sure you do not get too late to scoop up the bargains.

Reliance CPSE ETF (FFO3): Should You Invest?(Outside View)

Nov 29, 2018

Personalfn's analysis note on Reliance Mutual Fund Central Public Sector Enterprises Exchange Traded Fund (CPSE ETF). Should you subscribe?

Safety Beats Growth in 2018(Chart Of The Day)

Nov 30, 2018

With the markets turning up, these are my top 7 stock picks.

Looking For Higher Interest Rates on Bank FDs? Read This!(Outside View)

Dec 5, 2018

Credit disbursement to the productive sectors of the economy such as infrastructure, engineering, food processing, textiles, and chemicals, among others is rising.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

MERCK LTD SHARE PRICE


Dec 12, 2018 11:31 AM

TRACK MERCK LTD

  • Track your investment in MERCK LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE MERCK LTD WITH

MARKET STATS